Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

Summary

This crossover study will investigate the pharmacokinetics of oral versus sublingual administration of 17-beta-estradiol in the trans-female population.

Timeline

Start

2022-12-29

Primary completion

2023-07-20

Completion

2023-07-20

Outcome

Outcome not reported

Stopped (Enrollment): “Inability to adequately recruit participants, need for additional study participants based on preliminary data collection”

Drugs

Indications